Literature DB >> 9307161

IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns.

D Klauwer1, W F Blum, S Hanitsch, W Rascher, P D Lee, W Kiess.   

Abstract

The insulin-like growth factors (IGF-I and IGF-II) and their binding proteins (IGFBPs) have been implicated in regulating fetal growth and development. The aim of this study was to determine whether fetal IGFs correlate with auxologic data at birth and/or gestational age. Venous cord blood was obtained from 138 healthy newborns immediately after birth and clinical data were recorded using a standardized data sheet. For the determination of IGF-I and IGF-II, IGFBP-blocked radioimmunoassays were used. A coated-tube immunoradiometric assay was applied for the measurement of free IGF-I. IGFBP-1, -2, and -3 were measured using specific radioimmunoassays. IGF-I levels were 61 +/- 21 ng ml(-1), median 61 ng ml(-1), range 19-114 ng ml(-1); IGF-II levels were 466 +/- 80 ng ml(-1), median 457 ng ml(-1), range 311-701 ng ml(-1); free IGF-I levels were 2.4 +/- 1.8 ng ml(-1), median 1.8 ng ml(-1), range 0.4-7.8 ng ml(-1). The concentration of IGFBP-1 was 144 +/- 110 ng ml(-1), median 113 ng ml(-1), range 20-626 ng ml(-1); that of IGFBP-2 was 1165 +/- 455 ng ml(-1), median 1119 ng ml(-1), range 440-3466 ng ml(-1). IGFBP-3 levels were 1272 +/- 280 ng ml(-1), median 1272 ng ml(-1), range 600-1966 ng ml(-1). IGF-I levels correlated significantly with IGFBP-3 levels (r = 0.71), birthweight (r = 0.48) and birth length (r = 0.37). There were significant inverse correlations between IGF-I and both IGFBP-1 (r = -0.45) and IGFBP-2 (r = -0.62). Although free IGF-I levels correlated (r = 0.71) with total IGF-I, only marginally significant correlations were found between free IGF-I and birthweight (r = 0.25). According to multiple regression analysis free IGF-I levels were only dependent upon total IGF-I, IGFBP-2 and IGFBP-1, whereas IGFBP-3 levels did not contribute to the variance of free IGF-I concentrations in venous cord blood. There was no significant correlation between IGF-II and auxologic data at birth. When IGF-I and IGFBP-3 levels were analysed with respect to gestational age a biphasic pattern with maxima at 270 d was observed. IGFBP-2 exhibited a reversed pattern with a minimum at 265 d of gestation. In conclusion, these data suggest that IGF-I and the IGFBPs, but not IGF-II, play a role in the regulation of late fetal growth and development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307161     DOI: 10.1111/j.1651-2227.1997.tb08605.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  21 in total

1.  Correlation of Insulin-Like Growth Factor-I and -II Concentrations at Birth Measured by Mass Spectrometry and Growth from Birth to Two Months.

Authors:  Colin P Hawkes; Deirdre M Murray; Louise C Kenny; Mairead Kiely; Jonathan O'B Hourihane; Alan D Irvine; Zengru Wu; Yair Argon; Richard E Reitz; Michael J McPhaul; Adda Grimberg
Journal:  Horm Res Paediatr       Date:  2018-01-18       Impact factor: 2.852

2.  Human placental GLUT1 glucose transporter expression and the fetal insulin-like growth factor axis in pregnancies complicated by diabetes.

Authors:  Marcus H Borges; Janet Pullockaran; Patrick M Catalano; Marc U Baumann; Stacy Zamudio; Nicholas P Illsley
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-05       Impact factor: 5.187

3.  Knockout maternal adiponectin increases fetal growth in mice: potential role for trophoblast IGFBP-1.

Authors:  Liping Qiao; Jean-Sebastien Wattez; Samuel Lee; Zhuyu Guo; Jerome Schaack; William W Hay; Matteo Moretto Zita; Mana Parast; Jianhua Shao
Journal:  Diabetologia       Date:  2016-08-05       Impact factor: 10.122

4.  Utilization of an endocrine growth index, insulin-like growth factor binding protein (IGFBP)-1b, for postsmolt coho salmon in the Strait of Georgia, British Columbia, Canada.

Authors:  Nobuto Kaneko; Meredith L Journey; Chrys M Neville; Marc Trudel; Brian R Beckman; Munetaka Shimizu
Journal:  Fish Physiol Biochem       Date:  2019-07-11       Impact factor: 2.794

5.  Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants.

Authors:  T Hytinantti; E M Rutanen; M Turpeinen; R Sorva; S Andersson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

6.  Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential.

Authors:  Nicole Mamelle; Magali Boniol; Olivier Rivière; Marie O Joly; Georges Mellier; Bernard Maria; Bernard Rousset; Olivier Claris
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

7.  Megalin Is Predominantly Observed in Vesicular Structures in First and Third Trimester Cytotrophoblasts of the Human Placenta.

Authors:  Tina Storm; Erik I Christensen; Julie Nelly Christensen; Tine Kjaergaard; Niels Uldbjerg; Agnete Larsen; Bent Honoré; Mette Madsen
Journal:  J Histochem Cytochem       Date:  2016-10-21       Impact factor: 2.479

8.  Higher Maternal Protein Intake during Pregnancy Is Associated with Lower Cord Blood Concentrations of Insulin-like Growth Factor (IGF)-II, IGF Binding Protein 3, and Insulin, but Not IGF-I, in a Cohort of Women with High Protein Intake.

Authors:  Karen M Switkowski; Paul F Jacques; Aviva Must; Marie-France Hivert; Abby Fleisch; Matthew W Gillman; Sheryl Rifas-Shiman; Emily Oken
Journal:  J Nutr       Date:  2017-06-07       Impact factor: 4.798

9.  Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight.

Authors:  S Apostolidou; S Abu-Amero; K O'Donoghue; J Frost; O Olafsdottir; K M Chavele; J C Whittaker; P Loughna; P Stanier; G E Moore
Journal:  J Mol Med (Berl)       Date:  2006-12-16       Impact factor: 4.599

Review 10.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.